BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ismail N, Ismail F, Omar SV, Blows L, Gardee Y, Koornhof H, Onyebujoh PC. Drug resistant tuberculosis in Africa: Current status, gaps and opportunities. Afr J Lab Med 2018;7:781. [PMID: 30568900 DOI: 10.4102/ajlm.v7i2.781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hajissa K, Marzan M, Idriss MI, Islam MA. Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2021;10:932. [PMID: 34438982 DOI: 10.3390/antibiotics10080932] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Baruch Baluku J, Musaazi J, Mulwana R, Bengo D, Sekaggya Wiltshire C, Andia-Biraro I. Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis. J Clin Tuberc Other Mycobact Dis 2020;21:100205. [PMID: 33294630 DOI: 10.1016/j.jctube.2020.100205] [Reference Citation Analysis]
3 Niaz Q, Godman B, Campbell S, Kibuule D. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications. Int J Clin Pharm 2020;42:1227-36. [PMID: 32458227 DOI: 10.1007/s11096-020-01056-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
4 Ogwang MO, Imbuga M, Ngugi C, Mutharia L, Magoma G, Diero L. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya. BMC Infect Dis 2021;21:1175. [PMID: 34809602 DOI: 10.1186/s12879-021-06887-x] [Reference Citation Analysis]
5 Manyazewal T, Woldeamanuel Y, Holland DP, Fekadu A, Blumberg HM, Marconi VC. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial. Trials 2020;21:383. [PMID: 32370774 DOI: 10.1186/s13063-020-04324-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
6 Edessa D, Adem F, Hagos B, Sisay M. Incidence and predictors of mortality among persons receiving second-line tuberculosis treatment in sub-Saharan Africa: A meta-analysis of 43 cohort studies. PLoS One 2021;16:e0261149. [PMID: 34890421 DOI: 10.1371/journal.pone.0261149] [Reference Citation Analysis]
7 Ondoa P, Ndlovu N, Keita MS, Massinga-Loembe M, Kebede Y, Odhiambo C, Mekonen T, Ashenafi A, Kebede A, Nkengasong J. Preparing national tiered laboratory systems and networks to advance diagnostics in Africa and meet the continent's health agenda: Insights into priority areas for improvement. Afr J Lab Med 2020;9:1103. [PMID: 33102173 DOI: 10.4102/ajlm.v9i2.1103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Bade AB, Mega TA, Negera GZ. Malnutrition is Associated with Delayed Sputum Culture Conversion Among Patients Treated for MDR-TB. Infect Drug Resist 2021;14:1659-67. [PMID: 33953577 DOI: 10.2147/IDR.S293461] [Reference Citation Analysis]
9 Mogashoa T, Melamu P, Derendinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, Mokomane M, Kgwaadira B, Rankgoane-Pono G, Tsholofelo TT, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S. Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana. Pathogens 2019;8:E208. [PMID: 31661825 DOI: 10.3390/pathogens8040208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
10 Baluku JB, Mugabe P, Mulwana R, Nassozi S, Katuramu R, Worodria W. High Prevalence of Rifampicin Resistance Associated with Rural Residence and Very Low Bacillary Load among TB/HIV-Coinfected Patients at the National Tuberculosis Treatment Center in Uganda. Biomed Res Int 2020;2020:2508283. [PMID: 32775411 DOI: 10.1155/2020/2508283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ssengooba W, Komakech K, Namiiro S, Byabajungu H, Nalunjogi J, Katagira W, Kimuli I, Joloba ML, Adakun S, Nakiyingi L, Torrea G, Kirenga BJ. Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda. J Clin Tuberc Other Mycobact Dis 2021;25:100286. [PMID: 34816021 DOI: 10.1016/j.jctube.2021.100286] [Reference Citation Analysis]
12 Gina P, Davids M, Dheda K. Manipulation of autophagy for host-directed tuberculosis therapy. Afr J Thorac Crit Care Med 2019;25. [PMID: 34286250 DOI: 10.7196/AJTCCM.2019.v25i2.014] [Reference Citation Analysis]